​UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), ...

UiPath announces agentic AI solutions for healthcare revenue cycle management at ViVE 2026, targeting medical records review, claim denials and prior authorization. The company argues that ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate as it looks to become an AI agent orchestration platform. UIPath's ...

UiPath Inc. (NYSE:PATH) is one of the worst AI stocks to invest in according to Reddit. On February 6, UiPath announced the acquisition of WorkFusion, which is a pioneer in AI agents specialized in ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

The automation industry has spent the past year racing to pursue AI agents. UiPath’s new Chief Marketing Officer Michael Atalla pushes back on what that rush implies – not because agents lack value, ...

AI-fueled growth, surging revenues and bold partnerships set up a showdown, but which stock among COHR and PATH has the stronger edge? Read on to find out.

UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...